Reversing Microvascular Dysfunction in Heart Failure With Preserved Ejection Fraction

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2024
This study will evaluate the impact of colchicine on the change in coronary flow reserve (CFR), a marker for coronary microvascular dysfunction (CMD), compared to placebo in patients with heart failure and ejection fraction above 40% (including patients with improved EF).
Epistemonikos ID: 3c20b5aa1c6b7c80b23f919960f4bc8bd6356f63
First added on: May 15, 2024